Gadot Biochemical Industries News
4 articles
growth-positive
Gadot Biochemical Industries upgrades minerals to address chlorate concerns in infant food formulations
Gadot Biochemical Industries has developed a manufacturing process to produce special grades of Tri Potassium Citrate (TPC) and Tri Sodium Citrate (TSC) that meet the regulatory requirements for chlorate content in infant food. This development allows the company to provide enough quantities of TPC and TSC for use in infant foods, contributing to safer and healthier infant nutrition globally. The company aims to encourage infant food producers in the EU to follow this regulation. The market for baby foods and infant formula is expected to grow significantly, presenting a growth-positive impact for Gadot Biochemical Industries.
CustomersPartners
growth-positive
Gadot Biochemical Industries launches citrate mineral line of sports nutrition ingredients
Gadot Biochemical Industries has launched Gadosport, a new nutrition-specific citrate mineral line for pre-, during, and post-workout. The launch of Gadosport provides an opportunity for market differentiation as many recovery sports drinks lack the mineral magnesium. The ingredient line includes three varieties, each targeting different needs of active individuals. Gadosport aims to provide proper mineral balance for better recovery and tailored sports nutrition. The article does not mention any specific partners, investors, or customers. The date of the event described in the article is not provided.
CustomersPartners
growth-negative
Fortissimo buys Gadot Biochemicals from Delek
Delek Group is selling Gadot Biochemical Industries to the Fortissimo fund for NIS 40 million. The sale does not include the land on which Gadot Biochemicals plant is located. Gadot Biochemicals has caused heavy losses for Delek Group in recent years. Completion of the deal is expected in two weeks, pending regulatory approval.
Acquisition
growth-positive
Gadot Biochemicals seeks to acquire co in US or Europe
Gadot Biochemical Industries Ltd., a subsidiary of Delek Group Ltd., plans to acquire a company in the US or Europe. The acquisition is expected to significantly increase the companys sales. Gadot Biochemical manufactures ingredients and fine chemicals for the food industry and is a global leader in its field. The companys core product, citric acid, has faced falling global prices, so Gadot Biochemical has shifted its strategy to focus on added value products related to citric acid production. The companys main growth engine is mineral fortifiers, which are produced from citric acid. Gadot Biochemical aims to expand its presence in the health food industry. In 2005, the company won an innovation award for its mineral line. The article was published on January 12, 2006.
Acquisition
